Skip to main content
The evolving landscape of primary hemophagocytic lymphohistiocytosis: Long-term outcomes following hematopoietic cell transplantation.
Child Opportunity Index at birth and asthma with recurrent exacerbations in the US ECHO program.
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: a PIDTC study.
JAK-inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID and EBMT IEWP retrospective study.
Post-Transplant Late Complications Increase Over Time for Patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) Landmark Study.
Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
NFKB2 haploinsufficiency identified via screening for IFNa2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3.